BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Cipla
Teva
Cerilliant
Mallinckrodt
Dow
Merck
McKinsey
Deloitte
US Department of Justice

Generated: January 17, 2018

DrugPatentWatch Database Preview

Sevoflurane - Generic Drug Details

« Back to Dashboard

What are the generic sources for sevoflurane and what is the scope of sevoflurane freedom to operate?

Sevoflurane
is the generic ingredient in three branded drugs marketed by Baxter Hlthcare, Halocarbon Prods, Shanghai Hengrui, Piramal Critical, and Abbvie, and is included in five NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sevoflurane has ninety-seven patent family members in thirty-seven countries.

There are five drug master file entries for sevoflurane. Five suppliers are listed for this compound.
Pharmacology for sevoflurane
Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia

US Patents and Regulatory Information for sevoflurane

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare SEVOFLURANE sevoflurane LIQUID;INHALATION 075895-001 Jul 2, 2002 AN RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 AN RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Piramal Critical SOJOURN sevoflurane LIQUID;INHALATION 077867-001 May 2, 2007 AN RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Halocarbon Prods SEVOFLURANE sevoflurane LIQUID;INHALATION 078650-001 Nov 19, 2007 AN RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 AN RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 AN RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 AN RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Shanghai Hengrui SEVOFLURANE sevoflurane LIQUID;INHALATION 203793-001 Nov 3, 2015 AN RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for sevoflurane

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 ➤ Subscribe ➤ Subscribe
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 ➤ Subscribe ➤ Subscribe
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for sevoflurane

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,677,492 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid ➤ Subscribe
6,083,514 Polymethylpentene container for an inhalation anesthetic ➤ Subscribe
6,558,679 Container for an inhalation anesthetic ➤ Subscribe
6,162,443 Container for an inhalation anesthetic ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for sevoflurane

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Federal Trade Commission
Fuji
Covington
Mallinckrodt
Farmers Insurance
Express Scripts
Merck
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot